February 18, 2021
Findings involving antibody effector functions could help improve design of next-generation COVID-19 antibody drugs. Of the nine treatments and preventives for COVID-19 authorized for emergency use by the Food and Drug Administration, three are drugs made from so-called monoclonal antibodies. Such drugs provide patients with ready-made antibodies that neutralize the […]